Higher serum lactic deydrogenase (LDH) levels predict a worse outcome in patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure (CPAP)

S. Aliberti, P. Tarsia, C. Canetta, A. M. Brambilla, G. Graziadei, G. Milani, L. Grazioli, R. Marcelli, R. Cosentini (Milan, Italy)

Source: Annual Congress 2004 - Treatment and outcome of acute respiratory failure
Session: Treatment and outcome of acute respiratory failure
Session type: Thematic Poster Session
Number: 670

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Aliberti, P. Tarsia, C. Canetta, A. M. Brambilla, G. Graziadei, G. Milani, L. Grazioli, R. Marcelli, R. Cosentini (Milan, Italy). Higher serum lactic deydrogenase (LDH) levels predict a worse outcome in patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure (CPAP). Eur Respir J 2004; 24: Suppl. 48, 670

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Higher serum C-reactive protein levels predict a worse outcome in patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure
Source: Eur Respir J 2004; 24: Suppl. 48, 92s
Year: 2004

Risk factors of mortality in patients with acute cardiogenic pulmonary edema (ACPE) treated with continuous positive airway pressure (CPAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 263s
Year: 2007

Acute versus acute on chronic respiratory acidosis in acute cardiogenic pulmonary edema (ACPE) treated with continuous positive airway pressure (CPAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 821s
Year: 2006

Continuous positive airway pressure (CPAP) treatment and systolic function in acute cardiogenic pulmonary edema (ACPE)
Source: Eur Respir J 2006; 28: Suppl. 50, 820s
Year: 2006

Continuous positive airway pressure (CPAP) among patients with cardiogenic pulmonary edema
Source: Eur Respir J 2003; 22: Suppl. 45, 402s
Year: 2003

Continuous positive airway pressure (CPAP) among patients with cardiogenic pulmonary edema
Source: Eur Respir J 2003; 22: Suppl. 45, 72s
Year: 2003

Effects of different levels of nasal continuous positive airways pressure (CPAP) in infants with severe acute bronchiolitis
Source: Eur Respir J 2006; 28: Suppl. 50, 264s
Year: 2006

Use of new simplified acute physiology score (SAPS II) in patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure
Source: Eur Respir J 2004; 24: Suppl. 48, 92s
Year: 2004

Predictors of continuous positive airway pressure (CPAP) response in severe hypoxaemic respiratory failure due to COVID-19 pneumonitis
Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19
Year: 2021


Non-invasive positive pressure ventilation (NIV) in COPD patients with acute hypercapnic respiratory failure (AHRF) and altered level of consciousness (LC)
Source: Annual Congress 2004 - Noninvasive ventilatory support in acute and chronic respiratory failure
Year: 2004


3 month continuous positive airway pressure (CPAP) therapy decreases serum lipids, but not homocysteine and leptin concentration in patients with OSAS
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009


Efficacy of non-invasive positive pressure ventilation (NIPPV) in cystic fibrosis (CF) patients with acute respiratory failure (ARF)
Source: Eur Respir J 2003; 22: Suppl. 45, 501s
Year: 2003

Low levels of nasal continuous positive airway pressure (CPAP) treatment in patients with congestive heart failure (CHF) and Cheyne-Stokes respiration (CSR)
Source: Eur Respir J 2001; 18: Suppl. 33, 505s
Year: 2001

Effect of increasing levels of pressure support (PS) with NIV on diaphragmatic function asessed using ultrasound and to identify indicators of NIV failure in patients of AECOPD with type 2 respiratory failure - Pilot study
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020

Evaluation of long-term effect of continuous positive airway pressure (CPAP) therapy on reduction of high sensitivity C-reactive protein (HSCRP) for patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2005; 26: Suppl. 49, 357s
Year: 2005

Effects of an acute exacerbation requiring hospitalisation (AE) on lung function, muscle force and serum IGF-I levels in male patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 564s
Year: 2002

The role of noninvasive positive pressure ventilation (NPPV) in the management of acute respiratory failure in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2002; 20: Suppl. 38, 278s
Year: 2002

Effects of continuous positive airway pressure (nCPAP) on pulmonary hemodynamics in COPD patients with overlap syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 568s
Year: 2004

The strength of association between in-hospital mortality of acute respiratory failure patients treated with noninvasive ventilation (NIV) and initial arterial blood (ABG) pH
Source: Annual Congress 2010 - Noninvasive ventilation: technical, logistical and organisational aspects
Year: 2010

Elevated serum erythropoietin level in obesity hypoventilation syndrome patients improved by nasal positive pressure ventilation therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 101s
Year: 2002